TORONTO, ONTARIO--(Marketwire - May 22, 2008) - Cannasat Therapeutics Inc. (TSX VENTURE: CTH), the developer of novel cannabinoid-based pharmaceutical products, today announced its results for the three months ended March 31, 2008.
TORONTO, ONTARIO--(Marketwire - May 22, 2008) - Cannasat Therapeutics Inc. (TSX VENTURE: CTH), the developer of novel cannabinoid-based pharmaceutical products, today announced its results for the three months ended March 31, 2008.
